Krsnaa Diagnostics LimitedQ1 FY27 Results & Financial Update
Krsnaa Diagnostics Limited: Q1 FY27 consolidated results and company financials – revenue ₹235.53 Cr, PAT ₹16.55 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Krsnaa Diagnostics price & chart
Market priceLoading…
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Krsnaa Diagnostics Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Krsnaa Diagnostics reported consolidated revenue from operations of ₹2,35.53 crore (₹2,355 million) for the quarter ended June 30, 2026, supported by contributions from the established business and newly commissioned projects.
s in the earnings press release, revenue from operations grew by 22% year-on-year, while like-for-like projects expanded by approximately 12% year-on-year.
Profit after tax for the current quarter stood at ₹16.55 crore (₹166 million), yielding a PAT margin of approximately 7.03%, accompanied by basic earnings per share of ₹5.04.
The quarter marked a significant operational milestone as the major Rajasthan pathology network transitioned from implementation to full operations, contributing ₹257 million in quarterly revenue.
Profitability faced temporary moderation due to the upfront fixed cost base of the newly live Rajasthan infrastructure—comprising laboratories, specialized equipment, logistics, and personnel—carried ahead of full capacity utilization.
The retail segment demonstrated rapid scaling, with retail revenue growing approximately 64% year-on-year and 22% sequentially to ₹193 million as the retail footprint surpassed 4,250 touchpoints across five states.
Management noted that the performance reflects the typical rhythm of an infrastructure-led diagnostic model where initial capital expenditure and fixed operating costs precede utilization gains and subsequent operating leverage.
01 · Business model
What does Krsnaa Diagnostics do?
Krsnaa Diagnostics Limited operates as an integrated diagnostic services provider across India, specializing in both radiology and pathology modalities.
The company serves patients across 19 states and Union Territories through an extensive network utilizing structured public-private partnership (PPP) contracts alongside a growing standalone retail footprint.
Its operational model revolves around central processing laboratories, hub labs, and collection centers supported by integrated logistics and information technology platforms.
Revenue generation relies on a mix of long-term government healthcare contracts, institutional partnerships, and direct-to-consumer retail diagnostic testing.
02 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹235.53 Cr |
| Total income | ₹242.77 Cr |
| Profit before tax | ₹22.43 Cr |
| Profit after tax | ₹16.55 Cr |
| EPS | ₹5.04 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 7.0% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 9.5% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹7.24 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
03 · Why it moved
Why the quarter looked the way it did
What drove revenue
Established business operations continued to expand, with like-for-like projects registering approximately 12% year-on-year growth during the quarter.
The newly operational Rajasthan network contributed ₹257 million to top-line performance following its transition from implementation to active service delivery.
Retail operations expanded rapidly, delivering revenue of ₹193 million, representing a 64% year-on-year increase and a 22% sequential rise.
What drove margins
EBITDA margin moderated to 25% (compared to 27% in Q1 FY26), primarily driven by the upfront fixed cost base of laboratories, equipment, manpower, and logistics deployed for the Rajasthan network ahead of full utilization.
Management highlighted that the margin movement reflects the normal capital-intensive model where investments and fixed operating costs are established prior to volume ramp-up and subsequent operating leverage.
04 · Demand, customers & order book
Where demand is coming from
Krsnaa secured a new computed tomography (CT) project award in Himachal Pradesh encompassing 34 CT scanners.
05 · Segments, products & geography
Which parts of the business are doing the work
Geography and market mix
By the end of the quarter, the Rajasthan pathology network reached 31 operational mother labs, 62 hub labs, and 1,228 collection centers.
The company's retail network expanded to over 4,250 touchpoints across five states.
06 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
During the quarter, 8 out of 17 planned MRI centers in Maharashtra were successfully inaugurated and made operational.
The Apulki-Pune hospital commenced operations during the period.
07 · Strategy & new businesses
How the company is trying to change its growth mix
The Board of Directors approved the issuance of share warrants to the Promoter and Promoter Group, subject to receipt of applicable regulatory approvals and shareholder requirements.
08 · Reported developments
What changed operationally
The company secured 12 new National Accreditation Board for Testing and Calibration Laboratories (NABH) accreditations during the quarter.
Management stated that as capacity utilization builds across newly commissioned infrastructure and expanded retail touchpoints, inherent operating leverage is expected to become increasingly visible.
09 · Beyond the numbers
What changed beyond the numbers
Reported update
Executive Leadership Commentary
Managing Director Yash Mutha noted that Q1 FY27 demonstrates the growing strength of the built platform, with existing operations and new projects like Rajasthan creating a second layer of growth. Group CEO Mitesh Dave emphasized that execution focused on converting infrastructure into live, revenue-generating capacity.
10 · Key Q&A
The quarter, answered directly
What does Krsnaa Diagnostics do?
Krsnaa Diagnostics Limited operates as an integrated diagnostic services provider across India, specializing in both radiology and pathology modalities.
What is the clearest takeaway from Q1 FY27?
Krsnaa Diagnostics reported consolidated revenue from operations of ₹2,35.53 crore (₹2,355 million) for the quarter ended June 30, 2026, supported by contributions from the established business and newly commissioned projects.
What drove revenue or demand?
Established business operations continued to expand, with like-for-like projects registering approximately 12% year-on-year growth during the quarter.
What mattered most for margins or profitability?
EBITDA margin moderated to 25% (compared to 27% in Q1 FY26), primarily driven by the upfront fixed cost base of laboratories, equipment, manpower, and logistics deployed for the Rajasthan network ahead of full utilization.
What changed operationally beyond the headline numbers?
During the quarter, 8 out of 17 planned MRI centers in Maharashtra were successfully inaugurated and made operational.
What should the next disclosure help confirm?
Track the progressive capacity utilization and margin recovery across the 31 mother labs, 62 hub labs, and 1,228 collection centers in Rajasthan.
11 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
12 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Rajasthan Network Utilization: Track the progressive capacity utilization and margin recovery across the 31 mother labs, 62 hub labs, and 1,228 collection centers in Rajasthan.
- 02
Maharashtra MRI Rollout: Monitor the operationalization of the remaining 9 planned MRI centers out of the 17 total sanctioned in Maharashtra.
- 03
Himachal Pradesh CT Project Execution: Watch for project rollout updates regarding the newly secured 34 CT scanner project award in Himachal Pradesh.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.